Evaluating DeepSeek-R1 for gynecological oncology disease consultation in telemedicine: A comparative study with human doctors
-
By
-
Haojie Cai
-
Yaqian Zhao
-
Yongsong Wu
-
Yilin Liu
-
Shanshan Cheng
-
Yu Wang
-
July 7, 2026
-
Clinical Scorecard: Assessing DeepSeek-R1 for Telemedicine Consultations in Gynecological Oncology: A Comparison with Human Physicians
At a Glance
| Category | Detail |
| Condition | Gynecological Oncology |
| Key Mechanisms | Telemedicine utilizing AI for consultations and diagnostic recommendations. |
| Target Population | Women with gynecological oncology diseases. |
| Care Setting | Online medical consultation platforms. |
Key Highlights
- DeepSeek-R1 is evaluated against human physicians for telemedicine consultations.
- Telemedicine improves access to quality healthcare for women in developing countries.
- AI models like DeepSeek-R1 are gaining traction in gynecological oncology.
- Platforms like 'Ding Xiang Doctor' and 'Good Doctor Online' facilitate telemedicine services.
Guideline-Based Recommendations
Diagnosis
- Utilize telemedicine for early screening and diagnosis of gynecological cancers.
Management
- Incorporate AI-assisted consultations to enhance patient care in gynecological oncology.
Monitoring & Follow-up
- Regularly assess the effectiveness of AI models in providing accurate medical advice.
Risks
- Consider limitations of telemedicine, including cost and physician workload.
Patient & Prescribing Data
Women seeking consultations for gynecological oncology issues.
Telemedicine can provide timely medical advice and improve early detection rates.
Clinical Best Practices
- Leverage telemedicine platforms to increase access to gynecological oncology care.
- Ensure AI models are validated for clinical use in telemedicine.
Related Resources & Content